Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics and proteomics tools for the clinic.

F Rudert1

  • 1Xerion Pharmaceuticals GmbH, Fraunhoferstr 9, D-82152, Martinsried/Munich, Germany. f.rudert@xerion-pharma.com

Current Opinion in Molecular Therapeutics
|March 16, 2001
PubMed
Summary

Automated high-throughput technologies revolutionized human genome sequencing, enabling comprehensive molecular analysis. Innovations like biochips and lab-on-a-chip systems are advancing

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regulation of the human fas promoter by YB-1, Puralpha and AP-1 transcription factors.

Gene·2000
Same author

Functional genomics with protein-protein interactions.

Biotechnology annual review·2000
Same author

Selection of a peptide ligand to the p75 neurotrophin receptor death domain and determination of its binding sites by NMR.

Biochemical and biophysical research communications·1999
Same author

Silencer and enhancer regions in the human CD95 (Fas/APO-1) gene with sequence similarity to the granulocyte-macrophage colony-stimulating factor promoter: binding of single strand-specific silencer factors and AP-1 and NF-AT-like enhancer factors.

DNA and cell biology·1999
Same author

A phage-based system to select multiple protein-protein interactions simultaneously from combinatorial libraries.

FEBS letters·1998
Same author

Apoptosis through CD95 (Fas/APO-1), but not a CD40/CD95 chimeric receptor, is inhibited by phorbol-12-myristate-13-acetate.

DNA and cell biology·1997

Area of Science:

  • Genomics and Proteomics
  • Bioinformatics
  • Molecular Biology

Background:

  • Massively parallel automated high-throughput technologies were essential for human genome sequencing.
  • The integration of new hardware and software has driven significant advancements in biological research.

Purpose of the Study:

  • To explore the impact of high-throughput technologies on scientific research.
  • To discuss the evolution and potential of genomics and proteomics technologies.

Main Methods:

  • Development and application of automated high-throughput sequencing.
  • Utilization of biochip technology, including DNA chips for RNA expression profiling.
  • Advancement towards miniaturization and lab-on-a-chip concepts.

Main Results:

  • The trend towards 'industrialized science' is evident, with massive data generation from sequencing efforts.
  • Biochip principles and miniaturization are central to new genomics and proteomics technologies.
  • Emerging technologies are being applied to clinical sample analysis for disease and risk assessment.

Conclusions:

  • Lab-on-a-chip technology holds transformative potential for biological analysis.
  • While promising for diagnostics and prognostics, molecular profiling technologies require further validation for routine clinical use.

Related Experiment Videos